(MedPage Today) -- Ertugliflozin improved T2D control atop metformin/sitagliptin
via EASD: Novel SGLT2 Drug Works in Triple Therapy (CME/CE)
by
Showing posts with label EASD: Novel SGLT2 Drug Works in Triple Therapy (CME/CE). Show all posts
Showing posts with label EASD: Novel SGLT2 Drug Works in Triple Therapy (CME/CE). Show all posts
Thursday, September 15, 2016
Subscribe to:
Posts (Atom)